Literature DB >> 3410476

Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.

F J Gonzalez1, F Vilbois, J P Hardwick, O W McBride, D W Nebert, H V Gelboin, U A Meyer.   

Abstract

The enzyme P450db1 (db1) is responsible for the common human defect in drug oxidation known as the "debrisoquine/sparteine polymorphism." Polyclonal antibody against the rat db1 protein was used to screen a human liver lambda gt11 library for the db1 cDNA clone. A cDNA containing the full protein coding sequence was isolated; the deduced NH2-terminal sequence of this cDNA was identical to that derived from direct sequencing of the purified human db1 protein. Comparison of the human db1 with rat db1 revealed 71 and 73% similarities of nucleotides and amino acids, respectively. By use of human-rodent somatic cell hybrids the db1 gene was localized to human chromosome 22 (CYP2D locus).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410476     DOI: 10.1016/0888-7543(88)90100-0

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  28 in total

1.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

Review 2.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

3.  NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus.

Authors:  C Mura; J P Broyart; E Jacqz; J Elion; R Krishnamoorthy
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

4.  Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.

Authors:  T Aoyama; S Yamano; P S Guzelian; H V Gelboin; F J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 5.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

6.  The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter.

Authors:  N K Spurr; A C Gough; K Stevenson; C R Wolf
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

7.  The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.

Authors:  S Kimura; M Umeno; R C Skoda; U A Meyer; F J Gonzalez
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

Review 8.  Cytochrome P450 2D6.

Authors:  Ryan P Owen; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2009-07       Impact factor: 2.089

9.  Molecular characterization of lengthy mitochondrial DNA duplications from the parasitic nematode Romanomermis culicivorax.

Authors:  J L Azevedo; B C Hyman
Journal:  Genetics       Date:  1993-04       Impact factor: 4.562

Review 10.  Cardiovascular pharmacogenomics and individualized drug therapy.

Authors:  Naveen L Pereira; Richard M Weinshilboum
Journal:  Nat Rev Cardiol       Date:  2009-08-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.